Medicare Formulary Positioning Will Result In Pharma Mergers, Attorney Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Mergers could put some drug manufacturers in a better position to offer discounts to land formulary spots, Sidley Austin attorney Patrick Morrisey says. Formulary considerations will also drive greater manufacturer investment in pharmacoeconomic and comparative research, he says.